Product
COMIRNATY (BNT162b2)
1 clinical trial
2 indications
Indication
Acute Lymphoblastic LeukemiaIndication
Acute Myeloid LeukemiaClinical trial
Anti-Covid-19 Vaccine Protection in Immunocompromised Children (1 to 15 Years Old) With Acute Leukemia and Their Siblings (≥12 Years Old). Phase I-II Trial Evaluating Post-vaccine Safety and Humoral and Cellular Immunogenicity.Status: Completed, Estimated PCD: 2022-02-28